Systemic Anti-Cancer Therapy Data Set Overview
The Mandatory, Required or Optional (M/R/O) column indicates the recommendation for the inclusion of data.
- M = Mandatory: this data element is mandatory and the technical process (e.g. submission of the data set, production of output etc) cannot be completed without this data element being present
- R = Required: NHS business processes cannot be delivered without this data element
- O = Optional: the inclusion of this data element is optional as required for local purposes.
For guidance on the XML Schema constraints, see the Systemic Anti-Cancer Therapy Data Set XML Schema Constraints.
| DEMOGRAPHICS AND CONSULTANT |
|---|
| To carry personal, organisation and consultant details. One occurrence of this group is required. | |
| M/R/O | Data Set Data Elements |
| M | NHS NUMBER |
| M | PERSON BIRTH DATE |
| R | PERSON GENDER CODE CURRENT |
| R | ETHNIC CATEGORY |
| M | POSTCODE OF USUAL ADDRESS |
| R | GENERAL MEDICAL PRACTICE CODE (PATIENT REGISTRATION) |
| R | CONSULTANT CODE (INITIATED SYSTEMIC ANTI-CANCER THERAPY) |
| R | CARE PROFESSIONAL MAIN SPECIALTY CODE (START SYSTEMIC ANTI-CANCER THERAPY) |
| M | ORGANISATION CODE (CODE OF PROVIDER) |
| CLINICAL STATUS |
|---|
| To carry the clinical status details. One occurrence of this group is required. | |
| M/R/O | Data Set Data Elements |
| M | PRIMARY DIAGNOSIS (ICD AT START SYSTEMIC ANTI-CANCER THERAPY) and/or MORPHOLOGY (ICD-O AT START SYSTEMIC ANTI-CANCER THERAPY) |
| R | TNM CATEGORY (FINAL PRETREATMENT) |
| PROGRAMME AND REGIMEN |
|---|
| To carry details of the Systemic Anti-Cancer Therapy Programme and Systemic Anti-Cancer Drug Regimen. Multiple occurrences of this group are permitted (at least one must be present). | |
| M/R/O | Data Set Data Elements |
| R | SYSTEMIC ANTI-CANCER THERAPY PROGRAMME NUMBER |
| R | ANTI-CANCER REGIMEN NUMBER |
| R | DRUG TREATMENT INTENT |
| M | DRUG REGIMEN ACRONYM |
| R | PERSON HEIGHT IN METRES |
| R | PERSON WEIGHT |
| R | PERFORMANCE STATUS (ADULT) or PERFORMANCE STATUS (YOUNG PERSON) |
| R | CO-MORBIDITY ADJUSTMENT INDICATOR |
| R | DECISION TO TREAT DATE (ANTI-CANCER DRUG REGIMEN) |
| M | START DATE (ANTI-CANCER DRUG REGIMEN) |
| R | CLINICAL TRIAL INDICATOR |
| R | CHEMO-RADIATION INDICATOR |
| R | NUMBER OF SYSTEMIC ANTI-CANCER THERAPY CYCLES PLANNED |
| CYCLE |
|---|
| To carry details of each Systemic Anti-Cancer Therapy Cycle. Multiple occurrences of this group are permitted (at least one must be present). | |
| M/R/O | Data Set Data Elements |
| M | ANTI-CANCER DRUG CYCLE IDENTIFIER |
| R | START DATE (SYSTEMIC ANTI-CANCER DRUG CYCLE) |
| O | PERSON WEIGHT |
| R | PERFORMANCE STATUS (ADULT) or PERFORMANCE STATUS (YOUNG PERSON) |
| R | PRIMARY PROCEDURE (OPCS) |
| DRUG DETAILS |
|---|
| To carry details of the Systemic Anti-Cancer Therapy Drugs. Multiple occurrences of this group are permitted (one occurrence for each Systemic Anti-Cancer Therapy Drug - at least one must be present). | |
| M/R/O | Data Set Data Elements |
| R | SYSTEMIC ANTI-CANCER DRUG NAME |
| R | CHEMOTHERAPY ACTUAL DOSE |
| R | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |
| R | SYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION DATE |
| R | ORGANISATION CODE (CODE OF PROVIDER) |
| R | PRIMARY PROCEDURE (OPCS) |
| OUTCOME |
|---|
| To carry details of the outcome / summary. One occurrence of this group is permitted. | |
| M/R/O | Data Set Data Elements |
| R | START DATE (FINAL SYSTEMIC ANTI-CANCER THERAPY) |
| R | SYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (DOSE REDUCTION) |
| R | SYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (TIME DELAY) |
| R | SYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (DAYS REDUCED) |
| R | PLANNED TREATMENT CHANGE REASON |
| R | PERSON DEATH DATE |